OPEN END TURBO BEAR OPTIONSSCHEIN - ELI LILLY & CO | Real-time BOERSE MUENCHEN 11:42:04 2024-06-19 EDT | ||
| 5.82 EUR | -5.06% |
|
| Current month | -52.41% | ||
| 1 month | -63.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 5.82 | -5.06% |
| 24-06-18 | 6.13 | -2.70% |
| 24-06-17 | 6.3 | -11.02% |
| 24-06-14 | 7.08 | +2.61% |
| 24-06-13 | 6.9 | -16.67% |
Real-time BOERSE MUENCHEN
Last update June 19, 2024 at 11:42 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD2WNH |
| ISIN | DE000HD2WNH5 |
| Date issued | 2024-02-21 |
| Strike | 952.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 18.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.85 € |
|---|---|
| Lowest since issue | 5.7 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
891.5
USD
Average target price
855.4
USD
Spread / Average Target
-4.05%
- Stock Market
- Certificates
- Certificat
